Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000727553 | SCV000854782 | pathogenic | not provided | 2017-08-15 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000011973 | SCV001141741 | pathogenic | Duchenne muscular dystrophy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000011973 | SCV002126910 | pathogenic | Duchenne muscular dystrophy | 2024-08-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg768*) in the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Duchenne muscular dystrophy (PMID: 8499922, 32559196). This variant is also known as 2510C>T. ClinVar contains an entry for this variant (Variation ID: 11222). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000011973 | SCV000032207 | pathogenic | Duchenne muscular dystrophy | 1993-03-01 | no assertion criteria provided | literature only |